Ledger.Open graph →
SEC Form D · filed October 13, 2020

Emergo Therapeutics, Inc

Offering
$5.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Paul A. Berberian · Boulder, COExec · DirectorMary Kopczynski · New York, NYDirectorKevin D. King · New York, NYDirectorAlex F. Knowles · Los Angeles, CAExec · DirectorBarrett C. Gouger · Nixa, MODirectorMargaret E. Powell · Durham, NCDirectorJohn E. Bailey, Jr · Durham, NCDirectorMoise Khayrallah · Durham, NCExec · DirectorKip C. Glass · Nixa, MODirectorPeter J. Klein · New York, NYDirectorRobert E. Helmedag · Durham, NCDirectorCurt C. Hargis · Nixa, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Emergo Therapeutics, Inc. — SEC Form D filing (2020) | Ledger